tiprankstipranks
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market
Holding INBX?
Track your performance easily

Inhibrx Biosciences Inc (INBX) Ownership - Who Owns Inhibrx Biosciences Inc?

16 Followers

Inhibrx Biosciences Inc (INBX) Ownership Overview

26.98%5.95%34.25%7.29%25.52%
26.98% Insiders
34.25% Other Institutional Investors
7.29% ETFs
25.52% Public Companies and Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 47.50% of the company’s stock is owned by Institutional Investors, 26.98% is owned by Insiders, and 25.52% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 07, 2024
xxxxxxxxxxxxx
$100005
Sep 16, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$629117
Sep 12, 2024
xxxxxxxxxxxxx
$99992
Sep 10, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$671150

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,787,705Institution12.35%25,099,378
1,157,926Insider8.00%16,257,281
1,093,860Insider7.56%15,357,794
1,064,026Institution7.35%14,938,925
925,413Insider6.39%12,992,799
500,299Institution3.46%7,024,198
473,888Insider3.27%6,653,388
470,160Institution3.25%6,601,046
403,281Institution2.79%5,662,065
224,564Insider1.55%3,152,879

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
403,281Institution2.79%5,662,065
116,108Institution0.80%1,630,156
66,166Institution0.46%928,971
55,338Institution0.38%776,946
51,472Institution0.36%722,667
49,627Institution0.34%696,763
24,513Institution0.17%344,163
24,228Institution0.17%340,161
16,050Institution0.11%225,342
11,064Institution0.08%155,339

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
337,352Institution2.33%5,407,753
316,101Institution2.18%4,438,058
99,212Institution0.69%1,590,368
64,766Institution0.45%909,315
52,824Institution0.36%846,769
49,377Institution0.34%693,253
26,455Institution0.18%371,428
24,597Institution0.17%351,491
11,850Institution0.08%185,571
11,222Institution0.08%157,557

FAQ

Who Owns Inhibrx Biosciences Inc (INBX)?
According to the latest TipRanks data, approximately 34.25% of the company's stock is held by institutional investors, 26.98% is held by insiders, and 25.52% is held by retail investors.
    What percentage of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 34.25% of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors.
      What percentage of Inhibrx Biosciences Inc (INBX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.52% of Inhibrx Biosciences Inc (INBX) stock is held by retail investors.
        Who owns the most shares of Inhibrx Biosciences Inc (INBX)?
        Andreas Halvorsen owns the most shares of Inhibrx Biosciences Inc (INBX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis